1-173828321-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018122.5(DARS2):c.228-12C>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0181 in 1,370,752 control chromosomes in the GnomAD database, including 3,002 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.079 ( 1478 hom., cov: 30)
Exomes 𝑓: 0.011 ( 1524 hom. )
Consequence
DARS2
NM_018122.5 splice_polypyrimidine_tract, intron
NM_018122.5 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.001504
2
Clinical Significance
Conservation
PhyloP100: -0.138
Genes affected
DARS2 (HGNC:25538): (aspartyl-tRNA synthetase 2, mitochondrial) The protein encoded by this gene belongs to the class-II aminoacyl-tRNA synthetase family. It is a mitochondrial enzyme that specifically aminoacylates aspartyl-tRNA. Mutations in this gene are associated with leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL). [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 1-173828321-C-G is Benign according to our data. Variant chr1-173828321-C-G is described in ClinVar as [Benign]. Clinvar id is 137070.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-173828321-C-G is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.261 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DARS2 | NM_018122.5 | c.228-12C>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000649689.2 | NP_060592.2 | |||
DARS2 | NM_001365212.1 | c.228-12C>G | splice_polypyrimidine_tract_variant, intron_variant | NP_001352141.1 | ||||
DARS2 | NM_001365213.2 | c.228-12C>G | splice_polypyrimidine_tract_variant, intron_variant | NP_001352142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DARS2 | ENST00000649689.2 | c.228-12C>G | splice_polypyrimidine_tract_variant, intron_variant | NM_018122.5 | ENSP00000497569 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0786 AC: 11595AN: 147460Hom.: 1474 Cov.: 30
GnomAD3 genomes
AF:
AC:
11595
AN:
147460
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0219 AC: 5479AN: 250472Hom.: 656 AF XY: 0.0165 AC XY: 2240AN XY: 135512
GnomAD3 exomes
AF:
AC:
5479
AN:
250472
Hom.:
AF XY:
AC XY:
2240
AN XY:
135512
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0108 AC: 13234AN: 1223162Hom.: 1524 Cov.: 30 AF XY: 0.00958 AC XY: 5888AN XY: 614336
GnomAD4 exome
AF:
AC:
13234
AN:
1223162
Hom.:
Cov.:
30
AF XY:
AC XY:
5888
AN XY:
614336
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0788 AC: 11632AN: 147590Hom.: 1478 Cov.: 30 AF XY: 0.0768 AC XY: 5522AN XY: 71922
GnomAD4 genome
AF:
AC:
11632
AN:
147590
Hom.:
Cov.:
30
AF XY:
AC XY:
5522
AN XY:
71922
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:6
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 17, 2019 | This variant is associated with the following publications: (PMID: 28097321, 23065766, 27884173, 21427441) - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 16, 2016 | - - |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome Benign:4
Benign, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Mar 01, 2020 | Review of the variants reported in Reuter et al., 2017, PMID: 28097321: BS1,BS2 - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at